nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

20.08.2016 | Reply

Reply to: Starck et al.

verfasst von: Tim Van den Wyngaert, Frédéric Paycha

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Excerpt

We thank Starck and colleagues for sharing their thoughts regarding the recommendation that patients undergoing bone scintigraphy should be well hydrated and should be instructed to drink one or more litres of water during the time between tracer injection and imaging. They argue that insufficient justification is provided in the guideline document for this practice, which in their view may not improve—but rather degrade—image quality, and can result in larger bladder volumes that may obscure pelvic bone lesions [1]. …

Starck SÅ, Rosendahl L. Evaluation and optimization of administered activity, scanning parameters and hydration at (99m)Tc hydroxymethylene diphosphonate adult whole-body bone imaging. Clin Physiol Funct Imaging. 2012;32:431–6.CrossRefPubMed

SmPC Sodium Oxidronate (Technescan HDP®, Mallinckrodt Medical B.V.). In: The Medicines and Healthcare products Regulatory Agency. 2015. http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1452145923670.pdf. Accessed 21 Jul 2016.

SmPC Medronate (Medronate DRAXIMAGE®, DRAXIMAGE (UK) Limited). In: The Medicines and Healthcare products Regulatory Agency. 2013. http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1464323651245.pdf. Accessed 21 Jul 2016.

SmPC dicarboxypropane diphosphonate (TECEOS®, CIS BIO INTERNATIONAL). In: L’Agence nationale de sécurité du médicament et des produits de santé. 2012. http://base-donnees-publique.medicaments.gouv.fr/affichageDoc.php?specid=69793728&typedoc=R. Accessed 21 Jul 2016.

ICRP. Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007. Ann ICRP. 2008;38:1–197.CrossRefPubMed

Klemenz B, Katzwinkel J, Kaiser KP, Wieler HJ. The influence of differences in hydration on bone-to-soft tissue ratios and image quality in bone scintigraphy. Clin Nucl Med. 1999;24:483–7.CrossRefPubMed

Ferreira S, Cunha L, Fonseca A, Vieira D, Lemos J, Matias M, et al. Study of the influence of patient hydration in bone scintigraphy. Eur J Nucl Med Mol Imaging. 2009;36 Suppl 2:S237.

Titel: Reply to: Starck et al.
verfasst von: Tim Van den Wyngaert
Frédéric Paycha
Publikationsdatum: 20.08.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 12/2016
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-016-3488-0

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2016

Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer

Comments on Van den Wyngaert et al., The EANM practice guidelines for bone scintigraphy

Paraneoplastic syndrome demonstrated on 99mTc-HMDP bone scan

Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer

Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351

Feasibility and acceptance of simultaneous amyloid PET/MRI